PubRank

Massimiliano Di Filippo

Author PubWeight™ 31.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007 3.64
2 The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. J Neurosci 2011 1.76
3 Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol 2010 1.50
4 Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol 2007 1.47
5 A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 2006 1.11
6 Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord 2008 1.06
7 Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 2010 1.05
8 New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. Lancet Neurol 2013 0.99
9 Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J Neurosci 2010 0.97
10 Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 2012 0.96
11 Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 2008 0.94
12 Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 2006 0.91
13 Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 2007 0.91
14 New synaptic and molecular targets for neuroprotection in Parkinson's disease. Mov Disord 2012 0.89
15 Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. Brain 2009 0.86
16 Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. Proc Natl Acad Sci U S A 2012 0.86
17 Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci 2009 0.85
18 Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. Mov Disord 2008 0.84
19 Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci 2008 0.84
20 Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Biol Psychiatry 2010 0.83
21 Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases. Biochim Biophys Acta 2009 0.83
22 ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? Neuron 2008 0.83
23 A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation. PLoS One 2012 0.81
24 Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis. J Neurol 2010 0.80
25 Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. J Cereb Blood Flow Metab 2012 0.79
26 Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. Neuropharmacology 2008 0.77
27 A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity. Exp Neurol 2009 0.77
28 A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y. Brain 2013 0.77
29 Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis. Sci Rep 2016 0.76
30 Neuroscience: Brain's traffic lights. Nature 2010 0.76
31 Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. Stroke 2007 0.76
32 Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency. Eur Neurol 2016 0.75
33 A young patient with type C multiple system atrophy and hereditary hemochromatosis. J Neurol 2009 0.75